PCON debates MGD treatment, glaucoma testing, nutraceuticals

Hemphill, Nancy; Langley, Caitlin; Morgan, Daniel; Mullin, David W.
July 2011
Primary Care Optometry News;Jul2011, Vol. 16 Issue 7, p9
The article reports on some primacy care topics discussed in a session at the Optometry's Meeting in Salt Lake City, Utah on June 15 to 19, 2011, including unconventional therapies for meibomian gland dysfunction (MGD), visual field testing for glaucoma and nutraceuticals.


Related Articles

  • meibomitis, meibomiantis.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1429 

    A definition of the term "meibomitis" or "meibomiantis," which refers to the inflammation of the meibomian glands, is presented.

  • A Review of Primary Care Vision Screening. Berg, Pamela Hutt; Wheeler, David T. // American Orthoptic Journal;2009, Vol. 59, p98 

    Introduction and Background: Preschool vision screening (PVS) is an essential component of detecting treatable vision loss in young children. Many state screening programs are struggling to cope with unfunded mandates. Neither school nor community screenings are standardized, and often result in...

  • CE POST TEST WORKSHEET.  // Review of Optometry;5/15/2012 Meibomian Gland Disfuncti, p14 

    A quiz concerning the diagnosis and treatment of meibomian gland dysfunction (MGD) is presented.

  • Castor oil drops safely treat meibomian gland dysfunction Fluoroscein score, tear break-up time, tear evaporation rates improve significantly. Charters, Lynda // Ophthalmology Times;5/15/2003, Vol. 28 Issue 10, p38 

    Reports on the efficacy of castor oil eye drops as treatment for meibomian gland dysfunction in Chiba, Japan. Provision of lubrication to the eye; Improvement in the function of the lacrimal glands; Stabilization of the ocular surface.

  • Report elucidates meibomian gland dysfunction definition, diagnosis. Hasson, Matt; Preston, Courtney // Primary Care Optometry News;Jul2011, Vol. 16 Issue 7, p1 

    The article discusses a 2011 report from the International Workshop on Meibomian Gland Dysfunction, including recommended methods of clinical trial design, diagnosis and treatment of the meibomian gland dysfunction (MGD).

  • Ocular prostheses: not quite an eye for an eye. Malhotra, Raman // British Journal of Ophthalmology;Apr2013, Vol. 97 Issue 4, p383 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the morphologic changes in meibomian glands, contact lenses (CLs) polishing and meibomian gland dysfunction (MGD).

  • Reply to Tinley et al. Jain, V.; Sridhar, M. S.; Vaddavalli, P. K.; Sangwan, V. S. // Eye;Aug2008, Vol. 22 Issue 8, p1095 

    A response to the study regarding the contributing factors of meibomian gland dysfunction (MGD) which is published in the previous issues is presented.

  • Loteprednol etabonate.  // Reactions Weekly;4/20/2013, Issue 1449, p23 

    The article presents a case study of a 66-year old man who developed a ring infiltrate after receiving a topical administration of loteprednol etabonate for his chronic meibomitis.

  • Task force recommends early vision screening.  // Ophthalmology Times;7/1/2004, Vol. 29 Issue 13, p52 

    Reports on the issuance of recommendations by the U.S. Preventive Services Task Force on the importance of early screening of children in the primary care setting for vision problems. Effect of visual impairment on preschool-aged children; Methods for photoscreening; Significance of screening in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics